Work

Bringing a p53 hotspot mutation into reach of a T cell engager

Year: 2026
Type: article
Abstract: Mutations in TP53 occur across many cancers, yet the intracellular location of the p53 protein makes it difficult to target with traditional antibody-based therapies. However, mutant peptides, including those derived from p53, can be displayed by human leukocyte antigen (HLA) molecules on the cancer cell surface as peptide-HLA (pHLA) complexes, offering a route to selectively target intracellular mutant proteins. While potentially attractive, these pHLA complexes are often scarce on tumor cells and differ from their normal counterparts by only one amino acid, making selective recognition technically challenging.
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $3,900
OpenAlex ID: W7236198854
FWCI:
Cites: 6
Cited by:
Related to: 10